Literature DB >> 20478260

IGFBP7 is not required for B-RAF-induced melanocyte senescence.

Lyndee L Scurr1, Gulietta M Pupo, Therese M Becker, Ken Lai, David Schrama, Sebastian Haferkamp, Mal Irvine, Richard A Scolyer, Graham J Mann, Jürgen C Becker, Richard F Kefford, Helen Rizos.   

Abstract

Induction of senescence permanently restricts cellular proliferation after oncogenic stimulation thereby acting as a potent barrier to tumor development. The relevant effector proteins may therefore be fundamental to cancer development. A recent study identified IGFBP7 as a secreted factor mediating melanocyte senescence induced by oncogenic B-RAF, which is found commonly in cutaneous nevi. In contrast to the previous report, we demonstrate that B-RAF signaling does not induce IGFBP7 expression, nor the expression of the IGFBP7 targets, BNIP3L, SMARCB1, or PEA15, in human melanocytes or fibroblasts. We also found no correlation between B-RAF mutational status and IGFBP7 protein expression levels in 22 melanoma cell lines, 90 melanomas, and 46 benign nevi. Furthermore, using a lentiviral silencing strategy we show that B-RAF induces senescence in melanocytes and fibroblasts, irrespective of the presence of IGFBP7. Therefore, we conclude that the secreted protein IGFBP7 is dispensable for B-RAF(V600E)-induced senescence in human melanocytes. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478260     DOI: 10.1016/j.cell.2010.04.021

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  23 in total

Review 1.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

Review 2.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 3.  Generating new neurons to circumvent your fears: the role of IGF signaling.

Authors:  R C Agis-Balboa; A Fischer
Journal:  Cell Mol Life Sci       Date:  2013-03-30       Impact factor: 9.261

Review 4.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

5.  Multidrug resistance protein 3 loss promotes tumor formation by inducing senescence escape.

Authors:  C Wiel; B Gras; D Vindrieux; M Warnier; D Gitenay; B Le Calvé; M Ferrand; A Augert; D Bernard
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

Review 6.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

7.  Cellular senescence controls fibrosis in wound healing.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Aging (Albany NY)       Date:  2010-09       Impact factor: 5.682

Review 8.  Inside and out: the activities of senescence in cancer.

Authors:  Pedro A Pérez-Mancera; Andrew R J Young; Masashi Narita
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

9.  Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress.

Authors:  Amanda Croft; Kwang H Tay; Suzanah C Boyd; Su T Guo; Chen C Jiang; Fritz Lai; Hsin-Yi Tseng; Lei Jin; Helen Rizos; Peter Hersey; Xu D Zhang
Journal:  J Invest Dermatol       Date:  2013-08-06       Impact factor: 8.551

10.  Role for IGFBP7 in senescence induction by BRAF.

Authors:  Narendra Wajapeyee; Ryan W Serra; Xiaochun Zhu; Meera Mahalingam; Michael R Green
Journal:  Cell       Date:  2010-05-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.